Currently out of the existing stock ratings of Ann Hynes, 142 are a HOLD (36.79%), 244 are a BUY (63.21%).

Ann Hynes

Work Performance Price Targets & Ratings Chart

Analyst Ann Hynes, currently employed at MIZUHO, carries an average stock price target met ratio of 76.23% that have a potential upside of 12.35% achieved within 194 days.

Ann Hynes’s has documented 779 price targets and ratings displayed on 30 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on MD, Mednax at 19-Nov-2024.

Wall Street Analyst Ann Hynes

Analyst best performing recommendations are on PPD (PPD).
The best stock recommendation documented was for DPLO (DIPLOMAT PHARMACY) at 11/7/2017. The price target of $20 was fulfilled within 1 day with a profit of $1.25 (6.67%) receiving and performance score of 66.67.

Average potential price target upside

of $62.61 (15.15%) on UNH (UNITEDHEALTH GROUP ORPORATED).
of $46.07 (20.76%) on CI (CIGNA CORP).
of $42.33 (10.83%) on HUM (HUMANA).

ACHC Acadia Healthcare Company ANTM Anthem CAH Cardinal Health CI Cigna Corp CNC Centene Corp CVS CVS Health Corp DGX Quest Diagnostics orporated EHC Encompass Health Corp HCA HCA Holdings HUM Humana ICLR ICON PLC IQV IQVIA Holdings LH Laboratory of America Holdings MCK McKesson MD Mednax MOH Molina Healthcare PRAH PRA Health Sciences THC Tenet Healthcare UHS Universal Health Services WBA Walgreens Boots Alliance ABC AmerisourceBergen DPLO Diplomat Pharmacy EVHC Envision Healthcare Holdings PPD PPD RAD Rite Aid SYNH Syneos Health UNH UnitedHealth Group orporated ELV Elevance Health SGRY Surgery Partners IQ iQIYI

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Andrew Mok (BARCLAYS)